PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
50.42
-0.43 (-0.85%)
At close: Jun 18, 2025, 3:59 PM
50.43
0.02%
After-hours: Jun 18, 2025, 04:33 PM EDT
-0.85% (1D)
| Bid | 40 |
| Market Cap | 4B |
| Revenue (ttm) | 1.77B |
| Net Income (ttm) | 594.84M |
| EPS (ttm) | 6.51 |
| PE Ratio (ttm) | 7.75 |
| Forward PE | -21.57 |
| Analyst | Buy |
| Ask | 51.73 |
| Volume | 500,700 |
| Avg. Volume (20D) | 1,238,536 |
| Open | 50.73 |
| Previous Close | 50.85 |
| Day's Range | 50.20 - 51.28 |
| 52-Week Range | 28.72 - 58.38 |
| Beta | 0.51 |
About PTCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PTCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+12.63%
PTC Therapeutics shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
-18.62%
PTC Therapeutics shares are trading lower. The company announced results from the Phase 2 PIVOT-HD study of PTC518 in Stage 2 and Stage 3 Huntington's disease patients.
1 month ago · accessnewswire.com
Lost Money on PTC Therapeutics, Inc. (PTCT)? Possible Fraud - Contact Levi & Korsinsky TodayNEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning...